CHARACTERIZATION OF ANTIBODIES AGAINST BTN2A1 FOR Vδ2+ gd T CELL-BASED TUMOR IMMUNOTHERAPY

被引：0
作者：
Chan, Kok Fei [1 ,2 ]
Ostrouska, Simone [1 ,2 ]
Prasad, Ranjeeta [3 ]
Kurtov, Daria [3 ]
Hammet, Andrew [3 ]
Rigau, Marc [4 ]
Uldrich, Adam [4 ]
Behren, Andreas [1 ,2 ]
机构：
[1] La Trobe Univ, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia
[2] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia
[3] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, CSL Ltd, Parkville, Vic 3010, Australia
[4] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
ZOLEDRONATE; CHEMOTAXIS;
D O I：
10.1136/jitc-2022-SITC2022.0192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
192
引用
收藏
页码：A204 / A204
页数：1
相关论文
共 8 条
  • [1] Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
    Abe, Yu
    Muto, Masato
    Nieda, Mie
    Nakagawa, Yasunori
    Nicol, Andrew
    Kaneko, Touru
    Goto, Shigenori
    Yokokawa, Kiyoshi
    Suzuki, Kenshi
    [J]. EXPERIMENTAL HEMATOLOGY, 2009, 37 (08) : 956 - 968
  • [2] Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells
    Ashihara, Eishi
    Munaka, Tatsuya
    Kimura, Shinya
    Nakagawa, Saori
    Nakagawa, Yoko
    Kanai, Masaki
    Hirai, Hideyo
    Abe, Hirohisa
    Miida, Takashi
    Yamato, Susumu
    Shoji, Shuichi
    Maekawa, Taira
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 463 (04) : 650 - 655
  • [3] High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In Vivo
    Benzaid, Ismahene
    Moenkkoenen, Hannu
    Stresing, Verena
    Bonnelye, Edith
    Green, Jonathan
    Moenkkoenen, Jukka
    Touraine, Jean-Louis
    Clezardin, Philippe
    [J]. CANCER RESEARCH, 2011, 71 (13) : 4562 - 4572
  • [4] γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells
    Chan, Kok Fei
    Duarte, Jessica Da Gama
    Ostrouska, Simone
    Behren, Andreas
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
    Meraviglia, S.
    Eberl, M.
    Vermijlen, D.
    Todaro, M.
    Buccheri, S.
    Cicero, G.
    La Mendola, C.
    Guggino, G.
    D'Asaro, M.
    Orlando, V.
    Scarpa, F.
    Roberts, A.
    Caccamo, N.
    Stassi, G.
    Dieli, F.
    Hayday, A. C.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (02) : 290 - 297
  • [6] Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
    Rigau, Marc
    Ostrouska, Simone
    Fulford, Thomas S.
    Johnson, Darryl N.
    Woods, Katherine
    Ruan, Zheng
    McWilliam, Hamish E. G.
    Hudson, Christopher
    Tutuka, Candani
    Wheatley, Adam K.
    Kent, Stephen J.
    Villadangos, Jose A.
    Pal, Bhupinder
    Kurts, Christian
    Simmonds, Jason
    Pelzing, Matthias
    Nash, Andrew D.
    Hammet, Andrew
    Verhagen, Anne M.
    Vairo, Gino
    Maraskovsky, Eugene
    Panousis, Con
    Gherardin, Nicholas A.
    Cebon, Jonathan
    Godfrey, Dale I.
    Behren, Andreas
    Uldrich, Adam P.
    [J]. SCIENCE, 2020, 367 (6478) : 642 - +
  • [7] Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
    Sebestyen, Zsolt
    Prinz, Immo
    Dechanet-Merville, Julie
    Silva-Santos, Bruno
    Kuball, Jurgen
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (03) : 169 - 184
  • [8] γδ T Cells: The Ideal Tool for Cancer Immunotherapy
    Yazdanifar, Mahboubeh
    Barbarito, Giulia
    Bertaina, Alice
    Airoldi, Irma
    [J]. CELLS, 2020, 9 (05)
1